Goldman Sachs’s Avient AVNT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2016
Q4
– Sell
-200
Closed -$7K – 6886
2016
Q3
$7K Hold
200
– – ﹤0.01% 6904
2016
Q2
$7K Buy
+200
New +$7.05K ﹤0.01% 6896
2015
Q4
– Sell
-1,600
Closed -$47K – 7133
2015
Q3
$47K Buy
1,600
+1,500
+1,500% +$50.7K ﹤0.01% 6810
2015
Q2
$4K Buy
+100
New +$3.91K ﹤0.01% 7208
2015
Q1
– Sell
-3,800
Closed -$144K – 7066
2014
Q4
$144K Sell
3,800
-1,500
-28% -$54.8K ﹤0.01% 6383
2014
Q3
$189K Buy
5,300
+5,100
+2,550% +$200K ﹤0.01% 6213
2014
Q2
$8K Buy
+200
New +$7.83K ﹤0.01% 6928

Other funds holding AVNT

Goldman Sachs's AVNT Position: Q2 2026 in Review

Goldman Sachs increased its Avient (AVNT) stake by 71% in Q2 2026, buying an estimated $16.4M and bringing the position to 1,090,547 shares worth $40.3M. The position accounts for ﹤0.01% of the portfolio, ranked #1995.

Goldman Sachs first reported a position in AVNT in Q2 2013 and has held it in 53 quarters since. The position peaked at $156M in Q4 2021. 348 funds tracked by Wall St. Rank hold AVNT as of Q2 2026.

  • Goldman Sachs held 1,090,547 shares of Avient worth $40.3M as of Q2 2026.
  • Goldman Sachs bought 453,876 Avient shares in Q2 2026, an estimated $16.4M.
  • Avient made up ﹤0.01% of Goldman Sachs's portfolio in Q2 2026, its #1995 holding.
  • Goldman Sachs first reported a position in Avient in Q2 2013 and has held it in 53 quarters since.
  • Goldman Sachs's Avient position peaked at $156M in Q4 2021.
  • 348 funds tracked by Wall St. Rank held Avient as of Q2 2026.

Based on Goldman Sachs's 13F filing for Q2 2026, filed 14 Aug 2026.